Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

NCT04681729 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Cold Urticaria

Interventions

DRUG: Dupilumab SAR231893
DRUG: Placebo
DRUG: Non sedating H1-antihistamine

Sponsor

Sanofi

Collaborators

[object Object]